Current Signal Transduction Therapy
Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
  |
Contents
Current Signal Transduction Therapy, Volume 3 - Number 3
Alzheimers Disease and n-3 Polyunsaturated Fatty Acids: Beneficial Effects and Possible Molecular Pathways Involved
, 3(3): 152 - 157Gabriella Calviello, Simona Serini and Elisabetta Piccioni
DOI: 10.2174/157436208785699659
Unravelling the Complicated Networks of Integrin αIIbβ3 Signalling in Platelets
, 3(3): 158 - 167Karen S. Harris and Denise E. Jackson
DOI: 10.2174/157436208785699749
G Protein-Coupled Receptor-Receptor Tyrosine Kinase Receptor Crosstalk: Regulation of Receptor Sensitivity and Roles of Autocrine Feedback Loops and Signal Integration
, 3(3): 174 - 182J. Adolfo Garcia-Sainz, M. Teresa Romero-Avila, Tzindilu Molina-Munoz and Maria-Jose Garcia-Pasquel
DOI: 10.2174/157436208785699730
Pharmacological Modulation of p53 Function in Cancer Therapy
, 3(3): 183 - 194Razmik Mirzayans and David Murray
DOI: 10.2174/157436208785699721
GSK-3 Inhibitors: Recent Developments and Therapeutic Potential
, 3(3): 195 - 205Shinsuke Kaku, Shigeyuki Chaki and Makoto Muramatsu
DOI: 10.2174/157436208785699712
Shared Signaling Pathways Between Endocrine and Immune System Receptors: The Model of Gamma Chain
, 3(3): 206 - 214Claudio Pignata, Stefania Amorosi, Ilaria Russo, Donatella Capalbo, Teresa Lettiero, Marsilio Adriani and Mariacarolina Salerno
DOI: 10.2174/157436208785699695
Clinico-Pathologic and Biologic Predictors of EGFR Inhibitors Activity and Efficacy in Lung and in Colorectal Cancer
, 3(3): 234 - 243Maria Anna Bareschino, Clorinda Schettino, Linda Alvino, Cesare Gridelli and Fortunato Ciardiello
DOI: 10.2174/157436208785699668
Editor-in-Chief
Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net